Citation 177865

DE CLERCQ,E:. (1985). ANTIVIRAL AND ANTIMETABOLIC ACTIVITIES OF NEPLANOCINS.. 28(1)

Citation Details

TitleANTIVIRAL AND ANTIMETABOLIC ACTIVITIES OF NEPLANOCINS.
AuthorsDE CLERCQ,E:
Year1985
Volume28
Issue1

Summary

Year: 1985

Journal: Unknown

Organisms and Their Experiments (5)

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A
ACTIVE
2
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A
ACTIVE
3
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A
ACTIVE
4
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A
ACTIVE
5
CELL MORPHOLOGICAL ALTERATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A
ACTIVE
6
BETA-GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A
ACTIVE
7
FUMARASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A
ACTIVE
8
GUANYLATE CYCLASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A
ACTIVE
9
CELL MORPHOLOGICAL ALTERATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A
ACTIVE
10
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A
ACTIVE
11
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A
ACTIVE
12
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A
ACTIVE
13
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A
ACTIVE
14
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A
ACTIVE
15
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A
ACTIVE
16
BETA-GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A
INACTIVE
17
FUMARASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A
INACTIVE
18
GUANYLATE CYCLASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A
INACTIVE
19
CELL MORPHOLOGICAL ALTERATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A
INACTIVE
20
BETA-GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A
INACTIVE
21
FUMARASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A
ACTIVE
22
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A
INACTIVE
23
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A
INACTIVE
24
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A
INACTIVE
25
GUANYLATE CYCLASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A
ACTIVE
26
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A
ACTIVE
27
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A
ACTIVE
28
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A
ACTIVE
29
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A
ACTIVE
30
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A
ACTIVE
31
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A
ACTIVE
32
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A
ACTIVE
33
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN C
ACTIVE
2
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN C
ACTIVE
3
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN C
ACTIVE
4
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN C
ACTIVE
5
CELL MORPHOLOGICAL ALTERATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN C
ACTIVE
6
BETA-GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN C
ACTIVE
7
FUMARASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN C
ACTIVE
8
GUANYLATE CYCLASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN C
ACTIVE
9
CELL MORPHOLOGICAL ALTERATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN C
ACTIVE
10
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN C
ACTIVE
11
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN C
ACTIVE
12
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN C
ACTIVE
13
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN C
ACTIVE
14
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN C
ACTIVE
15
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN C
ACTIVE
16
BETA-GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN C
INACTIVE
17
FUMARASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN C
INACTIVE
18
GUANYLATE CYCLASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN C
ACTIVE
19
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN C
INACTIVE
20
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN C
INACTIVE
21
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN C
ACTIVE
22
CELL MORPHOLOGICAL ALTERATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN C
ACTIVE
23
BETA-GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN C
INACTIVE
24
FUMARASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN C
ACTIVE
25
GUANYLATE CYCLASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN C
ACTIVE
26
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN C
ACTIVE
27
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN C
ACTIVE
28
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN C
ACTIVE
29
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN C
ACTIVE
30
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN C
ACTIVE
31
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN C
ACTIVE
32
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN C
ACTIVE
33
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN C
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,ARA:
INACTIVE
2
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,ARA:
INACTIVE
3
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,ARA:
ACTIVE
4
DNA SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,ARA:
INACTIVE
5
RNA SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,ARA:
INACTIVE
6
PROTEIN SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,ARA:
INACTIVE
7
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,ARA:
ACTIVE
8
CELL MORPHOLOGICAL ALTERATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A,ARA:
INACTIVE
9
BETA-GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A,ARA:
INACTIVE
10
FUMARASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A,ARA:
INACTIVE
11
GUANYLATE CYCLASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A,ARA:
INACTIVE
12
CELL MORPHOLOGICAL ALTERATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A,ARA:
INACTIVE
13
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,ARA:
ACTIVE
14
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,ARA:
ACTIVE
15
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,ARA:
INACTIVE
16
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,ARA:
ACTIVE
17
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,ARA:
ACTIVE
18
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,ARA:
INACTIVE
19
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,ARA:
INACTIVE
20
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,ARA:
ACTIVE
21
CELL MORPHOLOGICAL ALTERATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A,ARA:
ACTIVE
22
BETA-GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A,ARA:
INACTIVE
23
FUMARASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A,ARA:
INACTIVE
24
GUANYLATE CYCLASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A,ARA:
INACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN D
INACTIVE
2
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN D
INACTIVE
3
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN D
INACTIVE
4
INSECTICIDE ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
NEPLANOCIN D
ACTIVE
5
CELL MORPHOLOGICAL ALTERATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN D
INACTIVE
6
BETA-GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN D
INACTIVE
7
FUMARASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN D
INACTIVE
8
GUANYLATE CYCLASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN D
INACTIVE
9
CELL MORPHOLOGICAL ALTERATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN D
INACTIVE
10
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN D
ACTIVE
11
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN D
ACTIVE
12
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN D
INACTIVE
13
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN D
ACTIVE
14
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN D
ACTIVE
15
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN D
ACTIVE
16
BETA-GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN D
INACTIVE
17
GUANYLATE CYCLASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN D
INACTIVE
18
FUMARASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN D
INACTIVE
19
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN D
INACTIVE
20
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN D
INACTIVE
21
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN D
ACTIVE
22
CELL MORPHOLOGICAL ALTERATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN D
INACTIVE
23
GUANYLATE CYCLASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN D
INACTIVE
24
FUMARASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN D
INACTIVE
25
BETA-GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN D
INACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,2'-DEOXY:
ACTIVE
2
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,2'-DEOXY:
INACTIVE
3
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,2'-DEOXY:
ACTIVE
4
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,2'-DEOXY:
ACTIVE
5
CELL MORPHOLOGICAL ALTERATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A,2'-DEOXY:
INACTIVE
6
BETA-GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A,2'-DEOXY:
INACTIVE
7
FUMARASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A,2'-DEOXY:
INACTIVE
8
GUANYLATE CYCLASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A,2'-DEOXY:
INACTIVE
9
INSECTICIDE ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,2'-DEOXY:
ACTIVE
10
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,2'-DEOXY:
ACTIVE
11
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,2'-DEOXY:
INACTIVE
12
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,2'-DEOXY:
ACTIVE
13
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,2'-DEOXY:
ACTIVE
14
CELL MORPHOLOGICAL ALTERATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A,2'-DEOXY:
INACTIVE
15
BETA-GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A,2'-DEOXY:
INACTIVE
16
FUMARASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A,2'-DEOXY:
INACTIVE
17
GUANYLATE CYCLASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A,2'-DEOXY:
INACTIVE
18
CELL MORPHOLOGICAL ALTERATION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A,2'-DEOXY:
INACTIVE
19
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,2'-DEOXY:
INACTIVE
20
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,2'-DEOXY:
INACTIVE
21
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
NEPLANOCIN A,2'-DEOXY:
ACTIVE
22
PROTEIN SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A,2'-DEOXY:
INACTIVE
23
DNA SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A,2'-DEOXY:
INACTIVE
24
RNA SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
NEPLANOCIN A,2'-DEOXY:
INACTIVE
Show SPARQL Queries (1)